Healthcare provider profile · identity verified

Jagdeep Kaur Mehrok, M.D

Family Practice · FONTANA, CA · NPI 1760558332

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	304	115
Amlodipine Besylate	Amlodipine Besylate	223	83
Metformin Hcl Er	Metformin Hcl	205	78
Levothyroxine Sodium	Levothyroxine Sodium	195	58
Losartan Potassium	Losartan Potassium	175	66
Rosuvastatin Calcium	Rosuvastatin Calcium	161	57
Cefadroxil	Cefadroxil	105	102
Alendronate Sodium	Alendronate Sodium	81	29
Omeprazole	Omeprazole	76	36
Lisinopril	Lisinopril	75	25
Pantoprazole Sodium	Pantoprazole Sodium	75	32
Glipizide	Glipizide	74	29
Gabapentin	Gabapentin	73	30
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	71	16
Doxycycline Monohydrate	Doxycycline Monohydrate	67	60
Meloxicam	Meloxicam	67	31
Albuterol Sulfate Hfa	Albuterol Sulfate	66	42
Duloxetine Hcl	Duloxetine Hcl	64	24
Azithromycin	Azithromycin	61	54
Metoprolol Tartrate	Metoprolol Tartrate	57	18
Trazodone Hcl	Trazodone Hcl	55	21
Azelastine Hcl	Azelastine Hcl	52	20
Atenolol	Atenolol	51	18
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	45	18
Hydrochlorothiazide	Hydrochlorothiazide	42	13
Bisoprolol Fumarate	Bisoprolol Fumarate	38	13
Ibuprofen	Ibuprofen	38	18
Donepezil Hcl	Donepezil Hcl	37	11
Simvastatin	Simvastatin	36	11
Metformin Hcl	Metformin Hcl	35	13
Prednisone	Prednisone	35	30
Jardiance	Empagliflozin	33	12
Potassium Chloride	Potassium Chloride	33	14
Escitalopram Oxalate	Escitalopram Oxalate	32	12
Fluoxetine Hcl	Fluoxetine Hcl	32	14
Clopidogrel	Clopidogrel Bisulfate	30	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	29	13
Furosemide	Furosemide	28	12
Propranolol Hcl	Propranolol Hcl	28	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	27	20
Fluconazole	Fluconazole	24	18
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	24	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	24	22
Hydrocortisone	Hydrocortisone	23	19
Sertraline Hcl	Sertraline Hcl	22	suppressed
Lorazepam	Lorazepam	21	suppressed
Valacyclovir	Valacyclovir Hcl	21	11
Bupropion Xl	Bupropion Hcl	20	11
Metoprolol Succinate	Metoprolol Succinate	20	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	20	20
Trospium Chloride	Trospium Chloride	20	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	19	17
Memantine Hcl	Memantine Hcl	19	suppressed
Acyclovir	Acyclovir	18	suppressed
Gavilyte-C	Peg3350/Sod Sulf,bicarb,cl/Kcl	18	18
Ipratropium Bromide	Ipratropium Bromide	18	13
Ofloxacin	Ofloxacin	18	18
Terazosin Hcl	Terazosin Hcl	18	suppressed
Allopurinol	Allopurinol	17	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	17	suppressed
Alprazolam	Alprazolam	15	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Estradiol	Estradiol	15	suppressed
Finasteride	Finasteride	15	suppressed
Ketoconazole	Ketoconazole	15	suppressed
Naltrexone Hcl	Naltrexone Hcl	15	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	14	14
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	13
Chlorthalidone	Chlorthalidone	14	suppressed
Lactulose	Lactulose	14	suppressed
Ondansetron Odt	Ondansetron	14	11
Quetiapine Fumarate	Quetiapine Fumarate	14	suppressed
Mirtazapine	Mirtazapine	13	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	13	suppressed
Pradaxa	Dabigatran Etexilate Mesylate	13	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	13	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	12	12
Amoxicillin	Amoxicillin	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Famotidine	Famotidine	12	suppressed
Hydralazine Hcl	Hydralazine Hcl	12	suppressed
Ezetimibe	Ezetimibe	11	suppressed
Montelukast Sodium	Montelukast Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error